Skip to content
Kheiron

See-mode is now part of DeepHealth

In 2024, See-Mode Technologies PTE LTD (“See-Mode”) became part of DeepHealth, a global leader in AI-powered health informatics. DeepHealth's mission is to empower breakthroughs in care through imaging by pushing the boundaries of what's possible in healthcare with advanced AI. The company enables operational efficiency, clinical confidence, and better delivery of care, while elevating the experience for care teams through human-centered, intuitive technology.

See-Mode technology leverages AI in innovative ways for ultrasound imaging. Its applications analyze thyroid and breast ultrasound images to improve diagnostic accuracy and efficiency, while generating standardized reports that streamline clinical workflows. With regulatory approvals in the United States, Canada, Australia, New Zealand, and Singapore, See-Mode's commercially available AI-powered detection, characterization, and reporting solutions for thyroid and breast are integrated into DeepHealth's Population Health portfolio as the Thyroid Suite and Breast Suite.

DeepHealth
2017

See-Mode Technologies founded in Singapore

2020

First FDA regulatory clearance for software that automates analysis and reporting of vascular ultrasound scans

2023

FDA clearance for AI-powered detection and classification of thyroid nodules

2024

See-Mode becomes part of DeepHealth

thyroid

Thyroid Suite

Thyroid Suite streamlines thyroid ultrasound by automating sonographer tasks, simplifying radiologist interpretation, and reducing non-clinical work—improving accuracy, efficiency, and consistency in care.

Find out more
Disclaimers: Not all products and functionalities are commercially available in all countries. For clearance and commercial availability in your geography of functionalities listed and compatibility with other systems, please contact us.